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The office of the European Journal of Clinical Microbiology
and Infectious Diseases (EJCMID) has been a hectic place
over the past year. With the unfortunate passing away of
founding editor Professor Ilja Braveny early 2007, a
passionate and dedicated Editor in Chief was lost. Professor
Braveny had enthusiastically led the journal for more than
two decades and he was the personification of EJCMID. In
Professor Braveny we lost a prominent and influential
representative of EJCMID. Professor Dana Milatovic filled
Prof. Braveny’s position for a number of months. This
guaranteed the journal’s continuity and we gratefully
acknowledge Professor Milatovic’s dedication and hard
work.
Springer, the publisher of EJCMID, has invited me to
take over the position of Editor in Chief from June 2007.
Since then, I have had ample opportunity to get to know the
journal from the inside. The journal is healthy: over the
summer period alone, more than 200 papers were submitted
and dealt with. Evaluation and judgment of such a number
of papers is a tough job which could not have been
performed without the administrative support of Nele Jung,
who is the heart of the office, and has been associated with
the EJCMID for a long time.
A significant fraction of the submissions involve brief
case reports and concise clinical observations. Although
from a historical perspective such manuscripts have always
formed an integral part of the EJCMID’s content, the
current editorial team will be changing policies over the
coming year and this will surely affect the number of short
communications with a clinical-practice focus that will be
included in future issues. It will be our long-term goal to
further improve the impact factor of EJCMID and we all
feel that in order to achieve this, changes in editorial policy
including this one are really necessary. There will be a
gradual change in the scope of the journal. Whereas the
current content of the journal represents, in a melting pot
manner, all aspects of clinical microbiology and infectious
diseases, we intend to re-orient and focus towards a smaller
number of clinical-scientific subjects. We may even
consider a new name. “Infectious Microbiology” would
neatly encapsulate the focus.
The journal will become a vehicle for post-genomic research
in the field of bacterial infectious diseases. It will specifically
focus on the publication of high quality manuscripts in any of
the following separate or, preferably, combined fields of
interest.
1. Epidemiology of bacterial virulence genes.
2. The genetics and phenotypes of host susceptibility to
bacterial infection.
3. Animal models of bacterial infections.
4. Imaging of bacterial infections
This will require a major change in the current policy of
the journal and we hope that it will not only lead to even
higher quality submissions and, therefore, publications, but
also to an additional group of readers. We will start to
implement these changes over the year to come by
introducing specific journal sections dedicated to the topics
listed above.
To introduce these changes is an editorial challenge, but it
willbe supported bycontinuityinthe impactfactor. Changing
aj o u r n a l ’s scope and header will not necessarily affect the
impactfactorandinthiswaythenewstartofEJCMIDwillnot
lead to a lesser impact and, thereby, a lower visibility.
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e-mail: a.vanbelkum@erasmusmc.nlEJCMID will—under a new name—provide a forum for the
dissemination of scientific data that integrate findings of the
various fields relating to bacterial infectious diseases and
medical microbiology. The ultimate goal is to describe the
etiology and development of bacterial infections in human or
animal hosts from a holistic and detailed perspective.
Epidemiological application of the assessment of genetic
variation of bacterial isolates can also be used to identify
virulence genes of interest. The interaction of virulence gene
productswithhumanoranimalhosts couldbevisualizedfrom
the genetic perspective: which are the host genes that define
the susceptibility or resistance to infections. Infectious
processes and their dynamics could also be studied using
imaging technologies. Papers to be published in EJCMID in
thefutureshouldoptimallybepositionedatthecuttingedgeof
the major topics listed above and should appreciate transla-
tional application of findings.
We will continue to publish full papers describing
innovative research. Next to original work, Full Reviews
and MiniReviews will be published. The journal will use
Editorial Manager as the electronic submission system.
Supported by a team of internationally renowned section
editors including a dedicated Reviews Editor, I will serve as
Editor in Chief. Although we are actively searching for
researchers knowledgeable in one of the four fields
identified above those interested in one of the editorial
positions are invited to express their interest.
I hope that we will be facing a healthy future for EJCMID
and that we will be able to guarantee continuity for the
journal once established by the late Professor Ilja Braveny. I
am looking forward to receiving the support of section
editors, our readership and, last but not least, the high quality
reviewers on whom EJCMID has always been able to rely.
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